Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Cash flows from operating activities:
Net income/(loss)	$ 1,658,478	$ (2,176,947)
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities
Stock-based compensation	72,648	198,871
Depreciation and amortization	327,540	275,426
Deferred income tax (benefit)/expense		(459,000)
(Increase)/decrease in operating assets
Accounts receivable	(692,719)	1,961,396
Contract assets	(1,240,143)	268,884
Inventories	19,146	116,546
Tax receivable	(1,528,305)
Other current assets	200,980	(24,622)
Increase/(decrease) in operating liabilities
Accounts payable	201,587	66,700
Accrued expenses	(422,268)	37,319
Contract liabilities	(671,167)	156,573
Deferred revenue	1,398,985	(4,247)
Total adjustments	(2,333,716)	2,593,846
Net cash (used in) provided by operating activities	(675,238)	416,899
Cash flows from investing activities:
Capital expenditures	(422,435)	(438,858)
Net cash used in investing activities	(422,435)	(438,858)
Cash flows from financing activities
Payments of long-term debt	(166,878)	(164,415)
Net cash used in financing activities	(166,878)	(164,415)
Net decrease in cash and cash equivalents	(1,264,551)	(186,374)
Cash and cash equivalents at beginning of period	8,664,253	11,439,361
Cash and cash equivalents at end of period	7,399,702	11,252,987
Supplemental disclosure of cash flow information:
Income taxes paid
Interest paid	115,852	112,461
Capitalization of right to use Asset		$ 150,000